StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $105 at Leerink Partners
October 30, 2024 6:26 AM
Leerink Partners analyst Joseph Schwartz lowered the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $105.00 (from $132.00) while ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
William Blair Downgrades BioMarin Pharmaceutical Inc. (BMRN) to Market Perform
October 30, 2024 6:10 AM
BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $81 at Citi
October 30, 2024 5:48 AM
BioMarin Pharma (BMRN) Tops Q3 EPS by 38c; raises guidance
October 29, 2024 4:05 PM
Form 8-K BIOMARIN PHARMACEUTICAL For: Oct 29
October 29, 2024 4:04 PM
BioMarin Announces 28% Y/Y Total Revenue Growth in the Third Quarter and Increase in Full-year 2024 Guidance; Reaffirms Long-term Guidance and Outlook
October 29, 2024 4:03 PM
